Notes
From an STS perspective, we recognise that the ‘discovery’ of the BRCA genes is part of a process of a social construction (Latour 2004a).
See for instance ‘Breast Cancer Gene-free Baby’ 9 January 2009, http://news.bbc.co.uk/2/hi/health/7819651.stm.
References
Ardern-Jones, J., Kenen, R., Lynch, E., Dohnerty, R. and Eeles, R. (2010) Is no news good news? Inconclusive genetic test results in BRCA1 and BRCA2 from patients and professionals’ perspectives. Hereditary Cancer in Clinical Practice 8 (1): 1–8.
Audeh, M.W. et al (2010) A multicentre phase II study of the oral PARP inhibitor olaparib (AZD2281; KU-0059436) in BRCA1 or BRCA2 mutation carriers with recurrent ovarian cancer. The Lancet 376 (9737): 245–251.
Bourret, P. (2005) BRCA patients and clinical collectives. Social Studies of Science 35 (1): 41–68.
Brodwin, P. (2002) Genetics, identity, and the anthropology of essentialism. Anthropological Quarterly 75 (2): 323–330.
Duster, T. (1990) Backdoor to Eugenics. New York: Routledge.
Dworkin, A.M., Huang, T.H.-M. and Toland, A.E. (2009) Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Seminars in Cancer Biology 19 (3): 165–171.
Epstein, S. (2007) Inclusion: The Politics of Difference in Medical Research. Chicago, IL: University of Chicago Press.
Finkler, K. (2000) Experiencing the New Genetics: Family and Kinship on the Medical Frontier. Philadelphia, PA: University of Pennsylvania Press.
Foucault, M. (2002) Archaeology of Knowledge, 2nd edn. London: Routledge.
Fullwiley, D. (2007) Race and genetics: Attempts to define the relationship. BioSocieties 2 (2): 221–237.
Gibbon, S. (2007) Breast Cancer Genes and the Gendering of Knowledge: Science and Citizenship in the Cultural Context of the ‘New’ Genetics. London: Palgrave Macmillan.
Gibbon, S. (2009) Genomics as public health? Community genetics and the challenge of personalised medicine in Cuba. Anthropology and Medicine Special Issue: Biomedical Technology and Health Inequities in the Global North and South 16: 131–147.
Gibbon, S. and Novas, C. (eds.) (2008) Biosocialities, Genetics and the Social Sciences: Making Biologies and Identities. London: Routledge.
Gottweis, H. (2009) Biopolitics in Asia. New Genetics and Society 28: 201–204.
Hallowell, N. (1999) Doing the right thing: Genetic risk and responsibility. Sociology of Health & Illness 21: 597–621.
Jasanoff, S. (2004) States of Knowledge: The Co-production of Science and the Social Order. London: Routledge.
Kalender, U. (2010) Genetic fate, epigenetic feasibility? Epigenetic notions of gender and environment. Paper presented at EASST 2010, Practicing Science and Technology, Performing the Social; September, Trento, Italy.
Kalender, U. (2010) Conditions in the womb. Epigenetic concepts of environment and gender. In: A. Vammé, G. Getzinger and B. Wieser (eds.) Yearbook 2010 of the Institute for Advanced Studies on Science, Technology and Society. Munich, Germany and Vienna, Austria: Profil.
Kampriani, E. (2009) Between religious philanthropy and individualized medicine: Situating inherited breast cancer in Greece. Biomedical Technology and Health Inequities in the Global North and South. Anthropology & Medicine Special Issue 16: 165–178.
King, M.C., Marks, J.H. and Mandell, J.B., for the New York Breast Cancer Study Group (2003) Breast and ovarian cancer risks due to inherited mutations In BRCA 1 and BRCA 2. Science 302: 643–646.
Klawiter, M. (2008) The Biopolitics of Breast Cancer: Changing Cultures of Disease and Activism. Minneapolis: University of Minnesota Press.
Landecker, H. (2007) How Cells Became Technologies. Harvard: Harvard University Press.
Latour, B. (2004a) Politics of Nature. How to Bring Science into Democracy. Harvard: Harvard University Press.
Latour, B. (2004b) Why has critique run out of steam? From matters of fact to matters of concern. Critical Inquiry 30: 225–248.
Lock, M. (2005) The eclipse of the gene and the return of divination. Medical Anthropology Quarterly 6 (5): 47–70.
Löwy, I. (2010) Preventive Strikes: Women, Precancer and Prophylactic Surgery. Baltimore, MD: The John Hopkins University Press.
Montoya, M.J. (2007) Bioethnic conscription: Genes, race, and Mexicana/o ethnicity in diabetes research. Cultural Anthropology 22 (1): 94–128.
zur Nieden, A. (2009) Die Verkörperung des genetischen Risikos: Gentests für Brust- und Eierstockkrebs aus der Sicht von ‘Betroffenen’. [The embodiment of genetic risk. Genetic testing for breast and ovarian cancer from the perspective of ‘affected’ women]. In: S. Dungs, U. Gerber and E. Mührel (eds.) Biotechnologie in Kontexten der Sozial- und Gesundheitsberufe. Professionelle Praxen – Disziplinäre Nachbarschaften – Gesellschaftliche Leitbilder. Frankfurt a. M.: Peter Lang Verlag, pp. 83–98 (in German).
Niewöhner, J. and Scheffer, T. (2008) Introduction. Comparative Sociology 7: 273–285.
Palfner, S. (2009) Gen-Passagen. Molekularbiologische und medizinische Praktiken im Umgang mit Brustkrebs-Genen. Wissen – Technologie – Diagnostik, [Gene-passages. Molecularbiological and Medical Practices Related to Breast Cancer Genes. Knowledge – Technology – Diagnostic] Bielefeld, Germany: Transcript (in German).
Parthasarathy, S. (2007) Building Genetic Medicine: Breast Cancer, Technology and the Comparative Politics of Health Care. Cambridge: MIT Press.
Raman, S. and Tutton, R. (2010) Life, science and biopower. Science, Technology and Human Values 35 (5): 711–734.
Risch, N., Burchard, E., Ziv, E. and Tang, H. (2002) Categorization of humans in biomedical research: Genes, race and disease. Genome Biology 3 (7), Comment 2007.01-2007.12.
Rose, N. and Novas, C. (2005) Biological citizenship. In: A. Ong and S.J. Collier (eds.) Global Assemblage: Technology, Politics and Ethics as Anthropological Problems. Oxford: Blackwell, pp. 439–463.
Strathern, M. (2004 [1991]) Partial Connections, updated edn. Lanham, MD: AtlaMira Press.
Sunder Rajan, K. (2006) Biocapital: The Constitution of Post-genomic Life. Durham, NC: Duke University Press.
Thompson, C. (2005) Making Parents: The Ontological Choreography of Reproductive Technologies. Cambridge, MA: The MIT Press.
Tutt, A. et al. (2010) Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial. The Lancet 376 (9737): 235–244.
Acknowledgements
The authors thank the editors of BioSocieties for agreeing to publish this special section on BRCA medicine and research. We are particularly grateful to Chloe Silverman for her help in this regard.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gibbon, S., Joseph, G., Kalender, U. et al. Special section: Perspectives on globalising genomics: The case of ‘BRCA’ breast cancer research and medical practice. BioSocieties 5, 407–414 (2010). https://doi.org/10.1057/biosoc.2010.36
Published:
Issue Date:
DOI: https://doi.org/10.1057/biosoc.2010.36